Intellectus Partners LLC Makes New Investment in Cardinal Health, Inc. $CAH

Intellectus Partners LLC purchased a new position in shares of Cardinal Health, Inc. (NYSE:CAH) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 4,424 shares of the company’s stock, valued at approximately $743,000.

Other large investors also recently added to or reduced their stakes in the company. Principal Financial Group Inc. lifted its stake in Cardinal Health by 5.3% during the first quarter. Principal Financial Group Inc. now owns 315,817 shares of the company’s stock worth $43,510,000 after purchasing an additional 15,956 shares in the last quarter. KLP Kapitalforvaltning AS lifted its stake in Cardinal Health by 4.0% during the second quarter. KLP Kapitalforvaltning AS now owns 114,198 shares of the company’s stock worth $19,185,000 after purchasing an additional 4,400 shares in the last quarter. Czech National Bank lifted its stake in Cardinal Health by 5.1% during the second quarter. Czech National Bank now owns 58,341 shares of the company’s stock worth $9,801,000 after purchasing an additional 2,857 shares in the last quarter. Zurich Insurance Group Ltd FI lifted its stake in Cardinal Health by 4,935.9% during the first quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company’s stock worth $130,434,000 after purchasing an additional 927,950 shares in the last quarter. Finally, Accurate Wealth Management LLC lifted its stake in Cardinal Health by 92.8% during the second quarter. Accurate Wealth Management LLC now owns 3,627 shares of the company’s stock worth $588,000 after purchasing an additional 1,746 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts have recently weighed in on the company. TD Cowen upped their price objective on Cardinal Health from $183.00 to $225.00 and gave the stock a “buy” rating in a research report on Monday. Jefferies Financial Group set a $220.00 price objective on Cardinal Health and gave the stock a “buy” rating in a research report on Monday. UBS Group upped their price objective on Cardinal Health from $185.00 to $220.00 and gave the stock a “buy” rating in a research report on Friday. Mizuho set a $210.00 price objective on Cardinal Health in a research report on Monday. Finally, Leerink Partners upped their price objective on Cardinal Health from $187.00 to $211.00 in a research report on Friday. Eleven research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $200.54.

Insider Transactions at Cardinal Health

In other Cardinal Health news, insider Ola M. Snow sold 28,151 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the transaction, the insider owned 15,431 shares of the company’s stock, valued at approximately $2,298,293.14. This trade represents a 64.59% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Jessica L. Mayer sold 38,078 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $5,666,767.96. Following the transaction, the insider directly owned 48,457 shares in the company, valued at approximately $7,211,370.74. The trade was a 44.00% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 271,676 shares of company stock valued at $40,489,525 over the last ninety days. Company insiders own 0.12% of the company’s stock.

Cardinal Health Price Performance

NYSE:CAH opened at $190.22 on Tuesday. The firm has a market capitalization of $45.19 billion, a PE ratio of 29.49, a price-to-earnings-growth ratio of 1.39 and a beta of 0.71. The business’s fifty day moving average price is $156.05 and its 200 day moving average price is $155.04. Cardinal Health, Inc. has a 12 month low of $110.63 and a 12 month high of $197.67.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, October 30th. The company reported $2.55 EPS for the quarter, beating the consensus estimate of $2.22 by $0.33. The firm had revenue of $64.01 billion for the quarter, compared to analyst estimates of $59.41 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.Cardinal Health’s revenue for the quarter was up 22.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.88 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, equities analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st were issued a $0.5107 dividend. This represents a $2.04 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend was Wednesday, October 1st. Cardinal Health’s dividend payout ratio is 30.77%.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.